Physician profile
Ruvan Shein
NPI 1356351514
$896.90
in general payments reported to CMS, 2019-2025
22 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $111 · 2021: $150 · 2022: $166 · 2023: $22.49 · 2024: $176 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $159.84 | 2021-2025 | |
| Novo Nordisk INC | $130.40 | 2019-2025 | Ozempic |
| Intercept Pharmaceuticals, INC. | $94.11 | 2020-2025 | |
| Hologic Sales and Service, LLC | $58.86 | 2024 | Aptima |
| Exact Sciences Corporation | $49.13 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.24 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $36.25 | 2022-2024 | Breztri |
| Pfizer INC. | $31.87 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $30.01 | 2024 | Contrave |
| Glaxosmithkline, LLC. | $28.08 | 2022-2024 | Nucala |
| Intra-Sana Laboratories | $25.91 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Amgen INC. | $25.82 | 2025 | Tavneos |
| Incyte Corporation | $23.11 | 2019 | |
| Daiichi Sankyo INC. | $22.00 | 2022 | |
| Janssen Biotech, INC. | $21.09 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $20.49 | 2019 | |
| Lilly USA, LLC | $18.45 | 2020 | |
| Endo Pharmaceuticals INC. | $17.88 | 2022 | |
| Gilead Sciences, INC. | $17.50 | 2025 | |
| Boston Scientific Corporation | $17.42 | 2022 | |
| Genentech USA, INC. | $16.50 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruvan Shein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.